pravastatin sodium
- Product NDC
- 65084-649
- 11-digit product format
- 650840649
- Labeler code
- 65084
- Product ID
- 65084-649_bb032def-fee5-42a8-e053-2a95a90a1e5c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- pravastatin sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- McKesson Corporation dba RX Pak
- Application
- ANDA077751
- Marketing category
- ANDA
- Marketing start
- 2010-03-30
- Marketing end
- 2021-06-30
- Substance
- PRAVASTATIN SODIUM
- Active strength
- 20 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 65084-649-10 | 65084064910 | 100 TABLET in 1 BOTTLE (65084-649-10) | 100 tablet | 2019-02-04 | 2021-06-30 | No | No | Current |
| 65084-649-41 | 65084064941 | 100 TABLET in 1 BOTTLE (65084-649-41) | 100 tablet | 2019-05-20 | 2021-06-30 | No | No | Current |